Spoken Alpha
GOSS
Gossamer Bio, Inc.
Overview
Gossamer Bio, Inc is a Healthcare company operating in Biotechnology with a $65.4M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 3, 2026).
5 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q3 FY20262026-11-03EPS— vs $-5.60—Rev— vs ——EODHD
- Q2 FY20262026-08-12EPS$-0.20 vs $-0.10-100.0%Rev$9.2M vs ——EODHD
- Q1 FY20262026-05-14EPS$-0.20 vs $-0.17-17.6%Rev$17.0M vs ——EODHD
- Q4 FY20252026-03-12EPS$-0.21 vs $-0.18-13.5%Rev$13.8M vs ——EODHD
- Q3 FY20252025-11-04EPS$-0.21 vs $-0.19-10.5%Rev$13.3M vs ——EODHD
- Q2 FY20252025-08-04EPS$-0.17 vs $-0.18+5.6%Rev$11.5M vs ——EODHD
- Q1 FY20252025-05-14EPS$-0.16 vs $-0.18+11.1%Rev$9.9M vs ——EODHD
- Q4 FY20242025-03-02EPS$-0.15 vs $-0.17+10.7%Rev$9.4M vs ——EODHD
- Q3 FY20242024-11-06EPS$-0.14 vs $-0.140.0%Rev$9.5M vs ——EODHD
- Q2 FY20242024-08-11EPS$0.22 vs $0.27-18.5%Rev$95.8M vs ——EODHD
- Q1 FY20242024-05-06EPS$-0.19 vs $-0.190.0%Rev$0 vs ——EODHD
- Q4 FY20232024-03-04EPS$-0.21 vs $-0.210.0%Rev$6.8M vs ——EODHD
- Q3 FY20232023-11-08EPS$-0.21 vs $-0.27+22.2%Rev$0 vs ——EODHD
- Q2 FY20232023-08-07EPS$-0.45 vs $-0.50+10.0%Rev$0 vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.52 vs $-0.54+3.7%Rev$0 vs ——EODHD
- Q4 FY20222023-03-16EPS$-0.59 vs $-0.62+4.8%Rev$0 vs ——EODHD
- Q3 FY20222022-11-02EPS$-0.65 vs $-0.66+1.5%Rev$0 vs ——EODHD
- Q2 FY20222022-08-08EPS$-0.74 vs $-0.69-7.2%Rev$0 vs ——EODHD
- Q1 FY20222022-05-09EPS$-0.76 vs $-0.760.0%Rev$0 vs ——EODHD
- Q4 FY20212022-03-02EPS$-0.74 vs $-0.740.0%Rev$0 vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-03 | — | $-5.60 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-12 | $-0.20 | $-0.10 | -100.0% | $9.2M | — | — | EODHD |
| Q1 FY2026 | 2026-05-14 | $-0.20 | $-0.17 | -17.6% | $17.0M | — | — | EODHD |
| Q4 FY2025 | 2026-03-12 | $-0.21 | $-0.18 | -13.5% | $13.8M | — | — | EODHD |
| Q3 FY2025 | 2025-11-04 | $-0.21 | $-0.19 | -10.5% | $13.3M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $-0.17 | $-0.18 | +5.6% | $11.5M | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-0.16 | $-0.18 | +11.1% | $9.9M | — | — | EODHD |
| Q4 FY2024 | 2025-03-02 | $-0.15 | $-0.17 | +10.7% | $9.4M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.14 | $-0.14 | 0.0% | $9.5M | — | — | EODHD |
| Q2 FY2024 | 2024-08-11 | $0.22 | $0.27 | -18.5% | $95.8M | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.19 | $-0.19 | 0.0% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-04 | $-0.21 | $-0.21 | 0.0% | $6.8M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-0.21 | $-0.27 | +22.2% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $-0.45 | $-0.50 | +10.0% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.52 | $-0.54 | +3.7% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-16 | $-0.59 | $-0.62 | +4.8% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-0.65 | $-0.66 | +1.5% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $-0.74 | $-0.69 | -7.2% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $-0.76 | $-0.76 | 0.0% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-02 | $-0.74 | $-0.74 | 0.0% | $0 | — | — | EODHD |
Source: EODHD. GOSS reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Faheem HasnainCEO5 yr 9 mo5 callsCurrent
- Bryan GiraudoCFO5 yr 2 mo5 callsCurrent
- Robert Paul Smith JrChief Commercial Officer2 yr 11 mono recorded callsCurrent
- Richard ArandaChief Medical Officer5 yr 5 mo4 callsCurrent
- Waage ChristianEVP, Tech Ops and Admin4 yr 8 mono recorded callsCurrent
- Caryn PetersonEVP, Regulatory Affairs5 yr 7 mo2 callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GOSS.
$ curl https://api.spokenalpha.com/v1/companies/GOSSFAQ
Frequently asked about GOSS
Where can I find Gossamer Bio, Inc.'s (GOSS) earnings call transcripts?
Spoken Alpha indexes GOSS's earnings call transcripts at https://spokenalpha.com/companies/GOSS. Each call links to attributed speakers and parsed analyst Q&A. Gossamer Bio, Inc.'s own investor relations page is at https://ir.gossamerbio.com/.
When was Gossamer Bio, Inc.'s most recent earnings call?
Gossamer Bio, Inc. (GOSS) held its most recent earnings call on 2026-05-18, covering fiscal Q1 2026.
What sector is GOSS in?
Gossamer Bio, Inc. (GOSS) operates in the Healthcare sector (Biotechnology industry).